Drd3

D(3) dopamine receptor (Dopamine D3 receptor)

Spatial tier: STRICT_EXCLUSIVE · Class: GPCR · Top region: OT (Olfactory tubercle) · Positive regions: 12/554

47.4Discovery Score
43.9Targetability Score
CEvidence grade C
What this means: Drd3: predicted fine-region profile is strict-exclusive, with 12 positive regions out of 554 (limit 12); direct spatial validation is required.
Priority review: This gene was requested explicitly and is shown even if the spatial gate rejected it. Treat this as a hypothesis/evidence record, not as a confirmed region-specific call.

Function in OT: evidence, prediction, innovation

Gene function
Drd3 encodes the dopamine D3 receptor, a Gi/o-coupled D2-like GPCR that inhibits cAMP/PKA signalling and reduces excitability. Higher dopamine affinity than D2 and restricted limbic distribution make it an antipsychotic and addiction target.
Region function
The olfactory tubercle is the olfactory ventral striatum: olfactory bulb and VTA dopamine input, D1/D2 spiny neurons, islands of Calleja, encoding odour valence and reward.
Published in this region
direct OT islands of Calleja granule cells are defined by D3 expression (Ridray et al. 1998: D1/D3 coexpression, opposing and synergistic, in islands and accumbens shell). Zhang et al. 2021: optogenetic activation of OT D3 neurons initiates self-grooming and suppresses ongoing behaviour; inhibition halts and ablation reduces grooming. Zhang et al. 2023: restraint stress lowers OT D3 excitability; ablation or inhibition gives depression-like behaviour, activation rescues it.
Predicted function
Prediction: D3 on island granule cells is an autoinhibitory brake on dopamine-driven excitability; agonists (PD128907) should suppress grooming initiation, antagonists (SB-277011A, PG01037) or OT-restricted Drd3 deletion should increase grooming. Conditional knockouts are needed because existing work manipulates the D3-Cre cell type, not the receptor.
Innovation
★★☆☆☆ 2/5 The D3 island cell type is heavily studied, but the receptor's own signalling role is not genetically isolated.
Tools
Tg(Drd3-cre)KI198Gsat BAC line (MMRRC) for OT islands, crossed with Ai9 tdTomato (JAX 007909) and Ai32 ChR2 (JAX 024109); Drd3 knockouts; agonists PD128907, 7-OH-DPAT; antagonists SB-277011A, PG01037, nafadotride; anti-D3 antibodies.
References

Direct evidence located at the region

Drd3 Allen ISH at the CCF centroid of OT

Allen ISH experiment 75038431, section image 74929625 (section 402): the section that contains the CCF centroid of Olfactory tubercle according to the Allen image-to-atlas alignment (reference_to_image), with a 2 mm window around that point. Left: whole section, red box = window. Middle: ISH signal. Right: Allen's expression-mask view of the same window. open this image in the Allen viewer

Direct spatial evidence

DIRECT ALLEN ISH
Allen ISH experiment 75038431, image 74929545 -- target region: OT (Olfactory tubercle)
Allen ISH experiment 75038431, image 74929545 -- target region: OT (Olfactory tubercle)
DIRECT ALLEN ISH
Allen ISH experiment 75038431, image 74929547 -- target region: OT (Olfactory tubercle)
Allen ISH experiment 75038431, image 74929547 -- target region: OT (Olfactory tubercle)

Regional expression figure

Drd3 regional expression profile

Predicted WMB × fine-CCF profile; not direct full-transcriptome spatial measurement.

CCF fine-region location

Drd3 CCF fine-region map

Region-centroid map colored by predicted expression; not a direct cellular expression image.

Spatial profile

OT
4.15
MMp
2.72
ACB
2.51
TMd
2.01
MMme
1.86
MMm
1.63
PMd
1.59
PVT
1.31
MMl
1
SI
0.98
FS
0.915
MEPO
0.901
PVp
0.863
DTN
0.719
OV
0.709
IA
0.683
CEAc
0.627
CP
0.572
MMd
0.551
PCN
0.535

Evidence and specificity

Evidence status
PREDICTED_FINE
Direct sources
None; predicted localization only
Exclusive threshold
12 positive regions out of 554
Spatial specificity
0.374
Top-region fraction
0.106
Filter status
PASS

Interpretation limits